LEADER 00817nam0-2200265---450- 001 990008853630403321 005 20090512115922.0 010 $a1-56670-410-3 035 $a000885363 035 $aFED01000885363 035 $a(Aleph)000885363FED01 035 $a000885363 100 $a20090512d2000----km-y0itay50------ba 101 0 $aeng 105 $aa-------001yy 200 1 $aDesign of Thermal Oxidation Systems for Volatile Organic Compounds$fDavid A. Lewandowski 210 $aBoca Raton$cLewis Publishers$dc2000 700 1$aLewandowski,$bDavid A.$0505670 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990008853630403321 952 $a04 093-16$bDIC 4841$fDINCH 959 $aDINCH 996 $aDesign of Thermal Oxidation Systems for Volatile Organic Compounds$9804676 997 $aUNINA LEADER 03088oam 2200625zu 450 001 9910219976803321 005 20240318141554.0 010 $a0-8330-6002-3 035 $a(CKB)3170000000065101 035 $a(SSID)ssj0000597644 035 $a(PQKBManifestationID)12256895 035 $a(PQKBTitleCode)TC0000597644 035 $a(PQKBWorkID)10577852 035 $a(PQKB)10895731 035 $a(oapen)doab114988 035 $a(EXLCZ)993170000000065101 100 $a20160829d2007 uy 101 0 $aeng 135 $aurmn|---annan 181 $ctxt 182 $cc 183 $acr 200 00$aAssessment of the AHRQ patient safety initiative : moving from research to practice evaluation report II (2003-2004 210 $cRAND Corporation$d2007 210 31$a[Place of publication not identified]$cRAND Health$d2007 215 $a1 online resource 225 0 $aTechnical report Assessment of the AHRQ patient safety initiative 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a0-8330-4148-7 327 $aIntroduction -- Context and input evaluations -- Process evaluation: monitoring progress and maintaining vigilance -- Process evaluation: patient safety epidemiology: effective practices and tools -- Process evaluation: building infrastructure for effective practices -- Process evaluation: achieving broader adoption of effective practices -- Product evaluation: selection of outcome measures. 330 $aUpdates the policy context of the Agency for Healthcare Research and Quality (AHRQ) patient safety initiative; documents the priorities and activities being undertaken; lays out an evaluation framework and possible measures of the effects on patient outcomes and on stakeholders other than patients. Discusses implications of the findings for future AHRQ policy, programming, and research; suggests ways to strengthen AHRQ activities. 517 0 $aAssessment of the Agency for Healthcare Research and Quality patient safety initiative 606 $aMedical errors$xPrevention$xGovernment policy$zUnited States 606 $aIatrogenic diseases$xPrevention$xGovernment policy$zUnited States 606 $aPatients$xSafety measures$zUnited States 606 $aMedical Errors$xprevention & control 606 $aProgram Evaluation 606 $aGovernment Programs 607 $aUnited States 615 0$aMedical errors$xPrevention$xGovernment policy 615 0$aIatrogenic diseases$xPrevention$xGovernment policy 615 0$aPatients$xSafety measures 615 12$aMedical Errors$xprevention & control. 615 22$aProgram Evaluation. 615 22$aGovernment Programs. 676 $a610.28/9 702 $aFarley$b Donna 712 02$aUnited States Agency for Healthcare Research and Quality 712 02$aRand Corporation, 712 02$aUnited States 801 0$bPQKB 906 $aBOOK 912 $a9910219976803321 996 $aAssessment of the AHRQ patient safety initiative : moving from research to practice evaluation report II (2003-2004$92872826 997 $aUNINA